S

Strand Therapeutics

Develops programmable, long-acting mRNA therapeutics

LNP Discovery Co-op

Bioprocess & BiomanufacturingPosted on Nov 13
InternshipBoston, MA, USA$25 - $28 /hrIn-person

About the Job

Requirements

  • Be on track to graduate with a Bachelor of Science or Master of Science in Biology, Biochemistry, Bioengineering, or a related discipline.
  • Be able to write, edit, and follow standard operating procedures.
  • Make careful observations and maintain clear and complete records of laboratory work.

Responsibilities

  • Execute formulation-related experiments, including preparing, optimizing, and characterizing lipid nanoparticle formulations.
  • Carry out bioassays to evaluate lipid nanoparticle formulations.
  • Perform general laboratory techniques, including sample preparation, cell culture, and nucleic acid work.
  • Work across diverse areas to support the group's research activities.

Desired Qualifications

  • Coursework related to dosage forms, drug or gene delivery systems, and nanotechnology.
  • Experience with production and analytical characterization of lipid nanoparticle formulations.

About the Company

Strand Therapeutics

Develops programmable, long-acting mRNA therapeutics

Strand Therapeutics develops programmable, long-acting mRNA therapeutics that aim to treat cancer and other life-threatening diseases. The product works by delivering mRNA engineered with logic-based circuits that sense disease-specific cell signals and activate only in diseased cells, increasing the therapeutic window and reducing harm to healthy cells. This enables multi-functional treatments with targeted action rather than non-specific delivery. The company differentiates itself by its programmable mRNA platform that combines gene-encoded logic with disease targeting to achieve cell-type–restricted activity, potentially allowing for safer and more precise therapies compared with conventional mRNA approaches. Strand Therapeutics pursues collaboration and partnerships to expand its programs and generate revenue through development and commercialization of its proprietary mRNA therapeutics with healthcare providers and institutions.

Company size
51-200
Company stage
Series B
Total funding
$256M
Headquarters
Boston, MA
Founded
2017

Recently Posted Jobs

Explore more opportunities at Strand Therapeutics

See more jobs